NASDAQ : ATAI
AtaiBeckley Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 7.35 USD (At close: Sep 10, 2026) · Market cap 2.73B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.73B |
| Enterprise Value | 2.50B |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 370.86M |
| Shares Outstanding | 370.86M |
| Shares Change (YoY) | +80.24% |
| Shares Change (QoQ) | +0.93% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 38.85% |
| Float | 362.95M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 609.54 |
| Forward PS | 6,246.80 |
| PB Ratio | 15.39 |
| P/TBV Ratio | 15.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 560.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.58 |
| Quick Ratio | 8.29 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -417.21% |
| Return on Assets (ROA) | -39.03% |
| Return on Invested Capital (ROIC) | -52.67% |
| Return on Capital Employed (ROCE) | -59.99% |
| Weighted Average Cost of Capital (WACC) | 12.76% |
| Revenue Per Employee | $45,172 |
| Profits Per Employee | -$6.75M |
| Employee Count | 99 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -2.97M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +50.31% |
| 50-Day Moving Average | 6.85 |
| 200-Day Moving Average | 4.72 |
| Relative Strength Index (RSI) | 61.81 |
| Average Volume (20 Days) | 13,789,832 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 19.20M |
| Short Previous Month | 16.86M |
| Short % of Shares Out | 5.18% |
| Short % of Float | 5.29% |
| Short Ratio (days to cover) | 2.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.47M |
| Gross Profit | -70.62M |
| Operating Income | -141.74M |
| Pretax Income | -671.26M |
| Net Income | -668.19M |
| EBITDA | -140.79M |
| EBIT | -141.74M |
| Loss Per Share | -$2.14 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 225.81M |
| Total Debt | 4.29M |
| Net Cash | 221.52M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 176.44M |
| Book Value Per Share | 0.48 |
| Working Capital | 216.22M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -127.10M |
| Capital Expenditures | 244,000 |
| Depreciation & Amortization | 951,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -126.86M |
| FCF Per Share | -$0.34 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | -3,169.54% |
| Pretax Margin | -15,010.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -80.24% |
| Shareholder Yield | -80.24% |
| Earnings Yield | -24.51% |
| FCF Yield | -4.65% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.12 |
| Price Target Difference | 10.48% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | -47.26% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.6 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |